.png){kind=icon}
返回
R
Raghava Kashyap
peter maccallum cancer center
18H指数
122论文数
1.1K被引数
收录论文 27
发表时间
.png){kind=icon}
Lutetium-177 [177Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial镥-177 [177Lu]Lu-PSMA-I&T 联合镭-223 治疗转移性去势抵抗性前列腺癌（AlphaBet 研究）：一项研究者发起、单中心、单臂、Ⅰ/Ⅱ期试验的期中分析.png)
PREAI
.png){kind=icon}
分享.png){kind=icon}
收藏First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta–Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study钽-161 [161Tb]Tb-PSMA-I&T双β–Auger放射性配体疗法在转移性去势抵抗性前列腺癌患者中的首次人体研究结果（VIOLET）：一项单中心、单臂、I/II期研究
PREAI
分享收藏
'Case of the Month' from Peter MacCallum Cancer Centre, Melbourne, Australia: insidious presentation of iatrogenic renal pelvis injury following ureteric cannulation with 5-F catheter diagnosed on unconventional mercaptoacetyltriglycine and single-photon emission computed tomography imaging.png)
BJU INTERNATIONAL
BJU INTERNATIONALIF4.4
PREAI
分享收藏